p53 as a therapeutic target

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• The p53 protein is a critical tumor suppressor, frequently inactivated in various cancers through mutation or negative regulation.
• Restoring functional p53 in tumors has demonstrated therapeutic potential, revitalizing interest in p53 as a drug target.

Purpose of the Study:

• To identify and develop small molecules that can counteract the loss of p53 function in cancer.
• To explore compounds that either reduce negative regulation of wild-type p53 or reactivate mutant p53.

Main Methods:

• Investigating small molecules for their ability to restore p53 tumor suppressor activity.
• Evaluating compounds for their potential to inhibit negative regulators of p53.
• Screening for small molecules capable of reactivating mutated p53 proteins.

Main Results:

• Several small molecules have been identified that show promise in addressing both non-mutated and mutated p53 scenarios.
• Some identified compounds may also mitigate side effects associated with conventional cancer treatments.

Conclusions:

• Emerging strategies focus on small molecules to harness the tumor-suppressing capabilities of p53.
• While promising, these therapeutic approaches are in early stages and require further validation.